Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Breast-conserving surgery in BRCA1/2 mutation carriers: are we approaching an answer?

Garcia-Etienne CA, Barile M, Gentilini OD, Botteri E, Rotmensz N, Sagona A, Farante G, Galimberti V, Luini A, Veronesi P, Bonanni B.

Ann Surg Oncol. 2009 Dec;16(12):3380-7. doi: 10.1245/s10434-009-0638-7.

PMID:
19649554
2.

Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature.

Kirova YM, Savignoni A, Sigal-Zafrani B, de La Rochefordiere A, Salmon RJ, This P, Asselain B, Stoppa-Lyonnet D, Fourquet A.

Breast Cancer Res Treat. 2010 Feb;120(1):119-26. doi: 10.1007/s10549-009-0685-6. Epub 2009 Dec 24. Review.

PMID:
20033769
3.

Radiotherapy for breast cancer in BRCA1/BRCA2 carriers: clinical issues and management dilemmas.

Pierce L.

Semin Radiat Oncol. 2002 Oct;12(4):352-61. Review.

PMID:
12382193
4.

Breast conservation in BRCA1 or BRCA2 mutation carriers with early stage breast cancer.

Phillips KA, McKay MJ.

Australas Radiol. 2001 May;45(2):200-4. Review.

PMID:
11380364
5.

Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis.

Valachis A, Nearchou AD, Lind P.

Breast Cancer Res Treat. 2014 Apr;144(3):443-55. doi: 10.1007/s10549-014-2890-1. Epub 2014 Feb 25. Review.

PMID:
24567198
6.

Prognosis of BRCA-associated breast cancer: a summary of evidence.

Bordeleau L, Panchal S, Goodwin P.

Breast Cancer Res Treat. 2010 Jan;119(1):13-24. doi: 10.1007/s10549-009-0566-z. Review.

PMID:
19789974
7.

Cumulative risk of second primary contralateral breast cancer in BRCA1/BRCA2 mutation carriers with a first breast cancer: A systematic review and meta-analysis.

Molina-Montes E, Pérez-Nevot B, Pollán M, Sánchez-Cantalejo E, Espín J, Sánchez MJ.

Breast. 2014 Dec;23(6):721-42. doi: 10.1016/j.breast.2014.10.005. Epub 2014 Nov 7. Review.

PMID:
25467311
8.

Effect of BRCA germline mutations on breast cancer prognosis: A systematic review and meta-analysis.

Baretta Z, Mocellin S, Goldin E, Olopade OI, Huo D.

Medicine (Baltimore). 2016 Oct;95(40):e4975. Review.

9.

Clinical relevance of normal and tumour cell radiosensitivity in BRCA1/BRCA2 mutation carriers: a review.

Bernier J, Poortmans P.

Breast. 2015 Apr;24(2):100-6. doi: 10.1016/j.breast.2014.12.003. Epub 2014 Dec 31. Review.

PMID:
25557581
10.

BRCA1/2 Mutation-associated Breast Cancer, Wide Local Excision and Radiotherapy or Unilateral Mastectomy: A Systematic Review.

Hallam S, Govindarajulu S, Huckett B, Bahl A.

Clin Oncol (R Coll Radiol). 2015 Sep;27(9):527-35. doi: 10.1016/j.clon.2015.06.001. Epub 2015 Jun 22. Review.

PMID:
26113392
11.

Ipsilateral breast tumor recurrence after breast-conserving therapy.

Panet-Raymond V, Truong PT, Watson PH.

Expert Rev Anticancer Ther. 2010 Aug;10(8):1229-38. doi: 10.1586/era.10.87. Review.

PMID:
20735309
12.

BRCA mutation testing in determining breast cancer therapy.

Smith KL, Isaacs C.

Cancer J. 2011 Nov-Dec;17(6):492-9. doi: 10.1097/PPO.0b013e318238f579. Review.

13.

Review of risk factors for the development of contralateral breast cancer.

Lizarraga IM, Sugg SL, Weigel RJ, Scott-Conner CE.

Am J Surg. 2013 Nov;206(5):704-8. doi: 10.1016/j.amjsurg.2013.08.002. Epub 2013 Sep 6. Review.

PMID:
24016706
14.
15.

Genetics and personal genomics for personalized breast cancer surgery: progress and challenges in research and clinical practice.

Ziogas D, Roukos DH.

Ann Surg Oncol. 2009 Jul;16(7):1771-82. doi: 10.1245/s10434-009-0436-2. Epub 2009 Mar 26. Review.

PMID:
19322611
16.

Hereditary breast cancer: clinical features and risk reduction strategies.

Paradiso A, Formenti S.

Ann Oncol. 2011 Jan;22 Suppl 1:i31-6. doi: 10.1093/annonc/mdq663. Review.

PMID:
21285148
17.

Contralateral risk-reducing mastectomy in sporadic breast cancer.

Murphy JA, Milner TD, O'Donoghue JM.

Lancet Oncol. 2013 Jun;14(7):e262-9. doi: 10.1016/S1470-2045(13)70047-0. Review.

PMID:
23725708
18.

Breast cancer: major risk factors and recent developments in treatment.

Majeed W, Aslam B, Javed I, Khaliq T, Muhammad F, Ali A, Raza A.

Asian Pac J Cancer Prev. 2014;15(8):3353-8. Review.

19.

Optimal surgical management for high-risk populations.

King TA, Pilewskie M, Morrow M.

Breast. 2015 Nov;24 Suppl 2:S91-5. doi: 10.1016/j.breast.2015.07.022. Epub 2015 Oct 1. Review.

PMID:
26432360
20.

Role of Breast Surgery in BRCA Mutation Carriers.

Nestle-Krämling C, Kühn T.

Breast Care (Basel). 2012 Oct;7(5):378-82. doi: 10.1159/000343717. Review.

Supplemental Content

Support Center